Following fields are empty!
Welcome to the University of Turku Journal Guide
The Journal Guide gives you peace of mind when selecting journals. If you are a researcher from the University of Turku you can look up your favorite journals or search and filter to get to a selection of journals that match your research. Select a funder to see whether the journals are compliant or not, and check the filter ‘Journals with agreements’ to limit the list to journals for which the APCs are fully or partially waived.
Anthropology of the Middle East
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Anthropos
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Anthropos: Jurnal Antropologi Sosial dan Budaya (Journal of Social and Cultural Anthropology)
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Anthropozoologica
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Anthrozoös: A multidisciplinary journal of the interactions between people and other animals
The Berg Journals Collection offers libraries online access to the full text of an expanding range of highly respected, interdisciplinary and peer-reviewed journals with a strong focus on culture and the visual arts. *A choice of 17 journals is available within the Collection in 2011. *All Berg journals offer authoritative peer-reviewed content, excellent functionality, unlimited user licenses, and COUNTER-compliant usage statistics. *Flexible access and pricing models for individual journals - as well as the full Collection - are available to libraries and library consortia worldwide.*Free 30-day institutional trials are available.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus vuosille 2025-2026 Taylor & Francisin kanssa koskee kaikkia T&F Open Select -lehtiä (eli hybridilehtiä) yhteiskuntatieteellisiltä, humanistisilta ja luonnontieteellisiltä aloilta ja Full OA-lehteä Annals of Medicine. Sopimus sisältää rajallisen määrän avoimesti julkaistavia artikkeleita. Avoimen julkaisemisen oikeus koskee vastaavia kirjoittajia.The FinELib consortium agreement with Taylor & Francis for the years 2025-2026 covers all T&F Open Select journals (i.e., hybrid journals) in the social sciences, humanities, and natural sciences and the full OA journal Annals of Medicine. The agreement includes a limited number of articles that can be published open access. OA publishing option without extra charge applies to corresponding authors.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Taylor & Francisin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Taylor & Francis Journals
Anthós
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Anti-Aging Eastern Europe
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Anti-Cancer Agents in Medicinal Chemistry
Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Anti-Cancer Drugs
Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion ja kustantajan välisen sopimuksen mukaan vastaavat kirjoittajat voivat julkaista artikkelinsa avoimena Lippincottin lehdissä sopimuskaudella 2024-2026 ilman avoimen julkaisemisen maksua (APC-maksu, Article Prosessing Charge). Maksuttomia avoimia artikkeleita on vuosittain käytössä rajattu määrä.According to the agreement between the FinELib consortium and the publisher, corresponding authors can publish their articles open access in Lippincott journals during the agreement period 2024-2026 without an article processing charge (APC). A limited number of free open access articles is available annually.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Lippincott lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Lippincott Journals
Anti-Corrosion Methods and Materials
ACMM provides practical research from around the world on the latest developments regarding the materials and techniques employed in corrosion prevention
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortio on solminut Emeraldin kanssa vuosille 2025-2026 sopimuksen, johon sisältyy vastaaville kirjoittajille mahdollisuus julkaista artikkeleita avoimena Emerald Premier -lehdissä ilmaisilla open access -vouchereilla. Vouchereita on rajallinen määrä.FinELib consortium’s agreement with Emerald for the years 2025-2026 offers corresponding authors an opportunity to publish their articles with a free open access voucher. There's a limited number of vouchers available.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Emeraldin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Emerald Journals
Anti-Infective Agents
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new anti-inflammatory & anti-allergy agents.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Anti-Trafficking Review
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antiarrhythmic effect of the Ca2+-activated K+ (SK) channel inhibitor ICA combined with either amiodarone or dofetilide in an isolated heart model of atrial fibrillation
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antibiotics
new antibiotics
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
Turun yliopiston affilioituneet tutkijat saavat sopimuskauden 1.3.2025-28.2.2026 aikana 10 %:n alennuksen MDPI:n julkaisemien lehtien APC-maksuista, sekä monografioiden BPC-maksuista. Kielen editointipalveluista kirjoittajat saavat 15 %:n alennuksen.As part of MDPI institutional open access program, University of Turku affiliated authors receive a 10 % discount on article processing charges (APCs) and on charges associated with open access book publishing with MDPI (BPCs) during the agreement period Mar 1, 2025 - Feb 28, 2026 . Authors will also receive 15 % discount on Language Editing Services.
- Ohjeita julkaisemiseen kustantajan sivuilla/Instructions on publishing on publisher's pages: Information for authors
Antibiotiki i Khimioterapiya
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antibodies
immunology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
Turun yliopiston affilioituneet tutkijat saavat sopimuskauden 1.3.2025-28.2.2026 aikana 10 %:n alennuksen MDPI:n julkaisemien lehtien APC-maksuista, sekä monografioiden BPC-maksuista. Kielen editointipalveluista kirjoittajat saavat 15 %:n alennuksen.As part of MDPI institutional open access program, University of Turku affiliated authors receive a 10 % discount on article processing charges (APCs) and on charges associated with open access book publishing with MDPI (BPCs) during the agreement period Mar 1, 2025 - Feb 28, 2026 . Authors will also receive 15 % discount on Language Editing Services.
- Ohjeita julkaisemiseen kustantajan sivuilla/Instructions on publishing on publisher's pages: Information for authors
Antibody Reports
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antibody Technology Journal
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Antibody Therapeutics
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELibin ja Oxford University Pressin vuosille 2026-2028 neuvotteleman Read & Publish -sopimuksen ansiosta OUP:n täysin avoimissa (fully OA) lehdissä julkaistujen artikkeleiden kirjoittajamaksuista vastaavat kirjoittajat saavat 15% alennuksen.FinELib’s Read & Publish agreement with Oxford University Press for the years 2026-2028 allows corresponding authors from participating institutions to publish Open Access in OUP’s fully OA journals with a 15% discount of the APC (Article Processing Charge) list price.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Oxford University Pressin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Oxford University Press Journals